Yuexin Lu, Jiahao Tang, Rong Zou, Chaobo Zheng, Ming Wang, Jianping Xiang, Shu Wan
{"title":"Single-Center Experience with AneuGuide™ Software-Assisted Flow Diverter Treatment for Complex Intracranial Aneurysms.","authors":"Yuexin Lu, Jiahao Tang, Rong Zou, Chaobo Zheng, Ming Wang, Jianping Xiang, Shu Wan","doi":"10.1016/j.wneu.2025.124501","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the efficacy and safety of flow diverters (FDs) guided by AneuGuide™ software in treating complex intracranial aneurysms.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 45 patients diagnosed with 48 complex intracranial aneurysms from August 2019 to December 2023. Among these, 21 aneurysms were treated with FDs implantation guided by AneuGuide™ software (ArteryFlow Technology, Hangzhou, China), and 27 aneurysms received FDs treatment without AneuGuide™ assistance. Immediate post-operative embolization rates, complication incidences, and clinical and imaging follow-up results were compared between the two groups.</p><p><strong>Results: </strong>A total of 49 FDs were implanted for the 48 aneurysms in the 45 patients, with 10 patients receiving additional coil embolization. No perioperative complications occurred. At 1-year follow-up, angiography showed: 9 aneurysms (18.8%) were grade B (partially visible), and 39 aneurysms (81.3%) were grade C or D (near-total occlusion), of which 37 (77.1%) were completely occluded (grade D). Multivariate cox regression analysis revealed that the AneuGuide™ group had a significantly higher complete occlusion rate at follow-up compared to the non-AneuGuide™ group (HR = 2.290, p = 0.044). One patient in the non-AneuGuide™ group developed in-stent stenosis without clinical symptoms. No new neurological deficits were observed in any of the patients during the follow-up period.</p><p><strong>Conclusion: </strong>FD placement for complex intracranial aneurysms assisted by AneuGuide™ software is a safe and effective treatment. Further prospective studies are needed to validate these findings.</p>","PeriodicalId":23906,"journal":{"name":"World neurosurgery","volume":" ","pages":"124501"},"PeriodicalIF":2.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.wneu.2025.124501","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the efficacy and safety of flow diverters (FDs) guided by AneuGuide™ software in treating complex intracranial aneurysms.
Methods: A retrospective analysis was conducted on 45 patients diagnosed with 48 complex intracranial aneurysms from August 2019 to December 2023. Among these, 21 aneurysms were treated with FDs implantation guided by AneuGuide™ software (ArteryFlow Technology, Hangzhou, China), and 27 aneurysms received FDs treatment without AneuGuide™ assistance. Immediate post-operative embolization rates, complication incidences, and clinical and imaging follow-up results were compared between the two groups.
Results: A total of 49 FDs were implanted for the 48 aneurysms in the 45 patients, with 10 patients receiving additional coil embolization. No perioperative complications occurred. At 1-year follow-up, angiography showed: 9 aneurysms (18.8%) were grade B (partially visible), and 39 aneurysms (81.3%) were grade C or D (near-total occlusion), of which 37 (77.1%) were completely occluded (grade D). Multivariate cox regression analysis revealed that the AneuGuide™ group had a significantly higher complete occlusion rate at follow-up compared to the non-AneuGuide™ group (HR = 2.290, p = 0.044). One patient in the non-AneuGuide™ group developed in-stent stenosis without clinical symptoms. No new neurological deficits were observed in any of the patients during the follow-up period.
Conclusion: FD placement for complex intracranial aneurysms assisted by AneuGuide™ software is a safe and effective treatment. Further prospective studies are needed to validate these findings.
期刊介绍：
World Neurosurgery has an open access mirror journal World Neurosurgery: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The journal''s mission is to:
-To provide a first-class international forum and a 2-way conduit for dialogue that is relevant to neurosurgeons and providers who care for neurosurgery patients. The categories of the exchanged information include clinical and basic science, as well as global information that provide social, political, educational, economic, cultural or societal insights and knowledge that are of significance and relevance to worldwide neurosurgery patient care.
-To act as a primary intellectual catalyst for the stimulation of creativity, the creation of new knowledge, and the enhancement of quality neurosurgical care worldwide.
-To provide a forum for communication that enriches the lives of all neurosurgeons and their colleagues; and, in so doing, enriches the lives of their patients.
Topics to be addressed in World Neurosurgery include: EDUCATION, ECONOMICS, RESEARCH, POLITICS, HISTORY, CULTURE, CLINICAL SCIENCE, LABORATORY SCIENCE, TECHNOLOGY, OPERATIVE TECHNIQUES, CLINICAL IMAGES, VIDEOS
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
